Anxiolytics and its Consume Increase as a Result of COVID-19 and “Pandemic Fatigue”
Abstract The COVID-19 has brought several negative consequences in different fields, being mental health one of the most important; and anxiety is one of the most frequent pathologies in that field. Several studies have related an increase in anxiety’s incidence as a direct consequence of the pandemic, as well as some risk and protective factors against anxiety. One of the most frequently used treatment against anxiety are benzodiacepines, so in our study we analyze the benzodiacepine consumption in a pharmacy in Valladolid. The 53?% of our sample started their treatment with benzodiacepines when the pandemic begun, and even a 20?% of the sample raised their dose. Moreover, we have observed an increase in the sales of benzodiacepines between years 2019 and 2020 in the pharmacy.
- Referencias
- Cómo citar
- Del mismo autor
- Métricas
Caycho-Rodríguez T, Barboza-Palomino M, Ventura-León J, Carbajal-León C, Noé-Grijalva M, Gallegos M et al. Traducción al español y validación de una medida breve de ansiedad por la COVID-19 en estudiantes de ciencias de la salud. Ansiedad y Estrés. 1 de julio de 2020; 26(2):174-180.
Gullo S, Misici I, Teti A, Liuzzi M, Chiara E. Going through the lockdown: a longitudinal study on the psychological consequences of the coronavirus pandemic. Res Psychother. 20 de enero de 2021; 23(3):494.
Hurlé MA, Monti J, J. Flórez J. Capítulo 27. Fármacos ansiolíticos y sedantes. Farmacología de los trastornos del sueño. En: Flórez J. Farmacología humana. 6a. Elsevier Masson; 2013.
McGinty EE, Presskreischer R, Han H, Barry CL. Psychological Distress and Loneliness Reported by US Adults in 2018 and April 2020. JAMA. 7 de julio de 2020; 324(1):93-94.
Murray B Stein, MD, MPH. COVID-19: Psychiatric illness. [Internet] [citado 20 de agosto de 2021]. Disponible en: https://www.uptodate.com/contents/covid-19-psychiatric-illness.
Pandemic fatigue - reinvigorating the public to prevent COVID-19: policy framework for supporting pandemic prevention and management: revised version November 2020 [Internet] [citado 16 de agosto de 2021]. Disponible en: https://www.euro.who.int/en/health-topics/health-emergencies/coronavirus-covid-19/publications-and-technical-guidance/2020/pandemic-fatigue-reinvigorating-the-public-to-prevent-covid-19,-september-2020-produced-by-whoeurope.
Santabárbara J, Lasheras I, Lipnicki DM, Bueno-Notivol J, Pérez-Moreno M, López-Antón R et al. Prevalence of anxiety in the COVID-19 pandemic: An updated meta-analysis of community-based studies. Prog Neuropsychopharmacol Biol Psychiatry. 13 de julio de 2021; 109:110207.
Trastornos de ansiedad - Síntomas y causas - Mayo Clinic [Internet] [citado 5 de agosto de 2021]. Disponible en: https://www.mayoclinic.org/es-es/diseases-conditions/anxiety/symptoms-causes/syc-20350961.
Wang C, Pan R, Wan X, Tan Y, Xu L, Ho CS et al. Immediate Psychological Responses and Associated Factors during the Initial Stage of the 2019 Coronavirus Disease (COVID-19) Epidemic among the General Population in China. Int J Environ Res Public Health. 6 de marzo de 2020; 17(5):E1729.
Gullo S, Misici I, Teti A, Liuzzi M, Chiara E. Going through the lockdown: a longitudinal study on the psychological consequences of the coronavirus pandemic. Res Psychother. 20 de enero de 2021; 23(3):494.
Hurlé MA, Monti J, J. Flórez J. Capítulo 27. Fármacos ansiolíticos y sedantes. Farmacología de los trastornos del sueño. En: Flórez J. Farmacología humana. 6a. Elsevier Masson; 2013.
McGinty EE, Presskreischer R, Han H, Barry CL. Psychological Distress and Loneliness Reported by US Adults in 2018 and April 2020. JAMA. 7 de julio de 2020; 324(1):93-94.
Murray B Stein, MD, MPH. COVID-19: Psychiatric illness. [Internet] [citado 20 de agosto de 2021]. Disponible en: https://www.uptodate.com/contents/covid-19-psychiatric-illness.
Pandemic fatigue - reinvigorating the public to prevent COVID-19: policy framework for supporting pandemic prevention and management: revised version November 2020 [Internet] [citado 16 de agosto de 2021]. Disponible en: https://www.euro.who.int/en/health-topics/health-emergencies/coronavirus-covid-19/publications-and-technical-guidance/2020/pandemic-fatigue-reinvigorating-the-public-to-prevent-covid-19,-september-2020-produced-by-whoeurope.
Santabárbara J, Lasheras I, Lipnicki DM, Bueno-Notivol J, Pérez-Moreno M, López-Antón R et al. Prevalence of anxiety in the COVID-19 pandemic: An updated meta-analysis of community-based studies. Prog Neuropsychopharmacol Biol Psychiatry. 13 de julio de 2021; 109:110207.
Trastornos de ansiedad - Síntomas y causas - Mayo Clinic [Internet] [citado 5 de agosto de 2021]. Disponible en: https://www.mayoclinic.org/es-es/diseases-conditions/anxiety/symptoms-causes/syc-20350961.
Wang C, Pan R, Wan X, Tan Y, Xu L, Ho CS et al. Immediate Psychological Responses and Associated Factors during the Initial Stage of the 2019 Coronavirus Disease (COVID-19) Epidemic among the General Population in China. Int J Environ Res Public Health. 6 de marzo de 2020; 17(5):E1729.
Villasán, V. J. ., Vaquero Velasco, R., & Calleja, M. A. (2022). Anxiolytics and its Consume Increase as a Result of COVID-19 and “Pandemic Fatigue”. FarmaJournal, 7(1), 71–82. https://doi.org/10.14201/fj2022717182
Downloads
Download data is not yet available.
+
−